Glenmark Pharma reports revenue growth of 5.6 per cent YoY Q4; 12.4 per cent for the full year FY 2021-22
Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the fourth quarter en
Americanorth America Glenn Saldanha Europeglenmark Europe Glenmark Lifesciences Glenmark Life Sciences Biosimilars Companies
Source: batonrougepost.com